Not applicableLooking for participantsNCT07169396What this trial is testingIdentifying Genetic Targets in Gynecological TumorsWho this might be right forOvarian Cancer Azienda USL Reggio Emilia - IRCCS 180
Testing effectiveness (Phase 2)UnknownNCT06161272What this trial is testingFluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPiWho this might be right forOvarian CancerHigh Grade Serous Adenocarcinoma of OvaryPrimary Peritoneal Carcinoma+1 more Guangxi Medical University 80
Early research (Phase 1)Active Not RecruitingNCT02627443What this trial is testingCarboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forMetastatic Fallopian Tube CarcinomaMetastatic Ovarian CarcinomaMetastatic Primary Peritoneal Carcinoma+9 more National Cancer Institute (NCI) 35
Early research (Phase 1)Looking for participantsNCT05005403What this trial is testingStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanWho this might be right forNon-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more AbbVie
Early research (Phase 1)Study completedNCT02179970What this trial is testingTo Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal CancersWho this might be right forPancreatic Adenocarcinoma MetastaticOvarian Serous AdenocarcinomaColorectal Cancer Metastatic CCTU- Cancer Theme 26
Early research (Phase 1)Study completedNCT02020707What this trial is testingNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersWho this might be right forCervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more Mayo Clinic 43
Testing effectiveness (Phase 2)Ended earlyNCT02569957What this trial is testingEffect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forMalignant Ovarian Endometrioid TumorMalignant Ovarian Serous TumorRecurrent Fallopian Tube Carcinoma+2 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 1
Not applicableStudy completedNCT05490407What this trial is testingRole of the ATP7A Transporter in Ovarian CancerWho this might be right forGynecologic CancerOvarian CancerHigh Grade Serous Carcinoma+1 more University Medical Centre Ljubljana 40
Large-scale testing (Phase 3)Active Not RecruitingNCT02839707What this trial is testingPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube High Grade Serous AdenocarcinomaOvarian High Grade Serous AdenocarcinomaOvarian Seromucinous Carcinoma+16 more National Cancer Institute (NCI) 444
Not applicableNot Yet RecruitingNCT07461207What this trial is testingA Translational Study to Explore and Overcome Metabolic-driven Resistance Mechanisms to Standard Chemotherapy in High-grade Ovarian CancerWho this might be right forHigh-grade Serous Ovarian Carcinoma (HGSOC) IRCCS Azienda Ospedaliero-Universitaria di Bologna 120
Not applicableNot Yet RecruitingNCT07721675What this trial is testingArtificial Intelligence-guided Precision Treatment of High-grade Serous Ovarian CarcinomaWho this might be right forHigh-grade Serous Ovarian Carcinoma (HGSOC) The Affiliated Hospital of Qingdao University 1,300
Not applicableStudy completedNCT06274541What this trial is testingUpfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA StudyWho this might be right forSerous Ovarian TumorEndometrioid Carcinoma OvaryFallopian Tube Cancer+1 more Cancer Trials Ireland 200
Not applicableLooking for participantsNCT06404671What this trial is testingTiming of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian CancerWho this might be right forOvarian Epithelial Cancer Alexandria University 250
Early research (Phase 1)Ended earlyNCT03585764What this trial is testingMOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma University of Pennsylvania 46
Early research (Phase 1)Study completedNCT03839524What this trial is testingA Trial Evaluating TG4050 in Ovarian Carcinoma.Who this might be right forOvarian CarcinomaFallopian Tube CancerPeritoneal Carcinoma Transgene 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06063070What this trial is testingFirst-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian CancerWho this might be right forOvarian CancerHigh Grade Serous Adenocarcinoma of OvaryHigh Grade Endometrioid Ovarian Cancer+2 more Sun Yat-sen University 44
Testing effectiveness (Phase 2)Looking for participantsNCT06639074What this trial is testingFolate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT TrialWho this might be right forAdvanced Fallopian Tube CarcinomaAdvanced Fallopian Tube High Grade Serous AdenocarcinomaAdvanced Ovarian Carcinoma+15 more Mayo Clinic 78
Not applicableEnded earlyNCT05891197What this trial is testingA Biomarker Screening Protocol for Participants With Solid TumorsWho this might be right forTriple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more Lyell Immunopharma, Inc. 10
Early research (Phase 1)Active Not RecruitingNCT04092270What this trial is testingA Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian CancerWho this might be right forEndometrial High Grade Endometrioid AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+26 more National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT07504588What this trial is testingSacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance TherapyWho this might be right forRecurrent Platinum-Sensitive Fallopian Tube Endometrioid AdenocarcinomaRecurrent Platinum-Sensitive Fallopian Tube High Grade Serous AdenocarcinomaRecurrent Platinum-Sensitive Ovarian High Grade Endometrioid Adenocarcinoma+3 more National Cancer Institute (NCI)